These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 24619848)

  • 1. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.
    Berg D; Postuma RB; Bloem B; Chan P; Dubois B; Gasser T; Goetz CG; Halliday GM; Hardy J; Lang AE; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M; Deuschl G
    Mov Disord; 2014 Apr; 29(4):454-62. PubMed ID: 24619848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arguing against the proposed definition changes of PD.
    Boeve BF; Dickson DW; Duda JE; Ferman TJ; Galasko DR; Galvin JE; Goldman JG; Growdon JH; Hurtig HI; Kaufer DI; Kantarci K; Leverenz JB; Lippa CF; Lopez OL; McKeith IG; Singleton AB; Taylor A; Tsuang D; Weintraub D; Zabetian CP
    Mov Disord; 2016 Nov; 31(11):1619-1622. PubMed ID: 27492190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The New Diagnostic Criteria for Parkinson's Disease.
    Postuma RB; Berg D
    Int Rev Neurobiol; 2017; 132():55-78. PubMed ID: 28554421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDS clinical diagnostic criteria for Parkinson's disease.
    Postuma RB; Berg D; Stern M; Poewe W; Olanow CW; Oertel W; Obeso J; Marek K; Litvan I; Lang AE; Halliday G; Goetz CG; Gasser T; Dubois B; Chan P; Bloem BR; Adler CH; Deuschl G
    Mov Disord; 2015 Oct; 30(12):1591-601. PubMed ID: 26474316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria.
    Martinez-Martin P; Falup-Pecurariu C; Rodriguez-Blazquez C; Serrano-Dueñas M; Carod Artal FJ; Rojo Abuin JM; Aarsland D
    Parkinsonism Relat Disord; 2011 Sep; 17(8):621-4. PubMed ID: 21684792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment.
    Goldman JG; Holden SK; Litvan I; McKeith I; Stebbins GT; Taylor JP
    Mov Disord; 2018 Apr; 33(4):503-510. PubMed ID: 29488270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the MDS clinical diagnostic criteria for Parkinson's disease.
    Postuma RB; Poewe W; Litvan I; Lewis S; Lang AE; Halliday G; Goetz CG; Chan P; Slow E; Seppi K; Schaffer E; Rios-Romenets S; Mi T; Maetzler C; Li Y; Heim B; Bledsoe IO; Berg D
    Mov Disord; 2018 Oct; 33(10):1601-1608. PubMed ID: 30145797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
    Goetz CG; Emre M; Dubois B
    Ann Neurol; 2008 Dec; 64 Suppl 2():S81-92. PubMed ID: 19127578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Criteria for Parkinson's Disease: From James Parkinson to the Concept of Prodromal Disease.
    Marsili L; Rizzo G; Colosimo C
    Front Neurol; 2018; 9():156. PubMed ID: 29628907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.
    Litvan I; Aarsland D; Adler CH; Goldman JG; Kulisevsky J; Mollenhauer B; Rodriguez-Oroz MC; Tröster AI; Weintraub D
    Mov Disord; 2011 Aug; 26(10):1814-24. PubMed ID: 21661055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
    Barton B; Grabli D; Bernard B; Czernecki V; Goldman JG; Stebbins G; Dubois B; Goetz CG
    Mov Disord; 2012 Feb; 27(2):248-53. PubMed ID: 22162144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive evaluation in Parkinson's disease: applying the Movement Disorder Society recommendations in a population with a low level of formal education.
    Rocha NP; Carreira EX; Prado ACA; Tavares F; Tavares M; Cardoso F; Jaeger A; Souza LC; Teixeira AL
    Arq Neuropsiquiatr; 2023 Feb; 81(2):119-127. PubMed ID: 36948198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
    Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
    Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach.
    Marras C; Fereshtehnejad SM; Berg D; Bohnen NI; Dujardin K; Erro R; Espay AJ; Halliday G; Van Hilten JJ; Hu MT; Jeon B; Klein C; Leentjens AFG; Mollenhauer B; Postuma RB; Rodríguez-Violante M; Simuni T; Weintraub D; Lawton M; Mestre TA
    Mov Disord; 2024 Mar; 39(3):462-471. PubMed ID: 38243775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDS research criteria for prodromal Parkinson's disease.
    Berg D; Postuma RB; Adler CH; Bloem BR; Chan P; Dubois B; Gasser T; Goetz CG; Halliday G; Joseph L; Lang AE; Liepelt-Scarfone I; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M; Deuschl G
    Mov Disord; 2015 Oct; 30(12):1600-11. PubMed ID: 26474317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New Diagnostic Criteria for Parkinson's Disease: MDS-PD Criteria].
    Watanabe H; Hara K; Ito M; Katsuno M; Sobue G
    Brain Nerve; 2018 Feb; 70(2):139-146. PubMed ID: 29433115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.
    Fereshtehnejad SM; Montplaisir JY; Pelletier A; Gagnon JF; Berg D; Postuma RB
    Mov Disord; 2017 Jun; 32(6):865-873. PubMed ID: 28429825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Prodromal Parkinson's Disease as Defined by MDS Research Criteria among Elderly Patients Undergoing Colonoscopy.
    Skorvanek M; Ladomirjakova Z; Han V; Lesko N; Feketeova E; Jarcuskova D; Repkova B; Spisak P; Urbancikova Z; Vargova A; Gombosova L; Zakuciova M; Veseliny E; Trebuna F; Mechirova E; Gdovinova Z
    J Parkinsons Dis; 2017; 7(3):481-489. PubMed ID: 28387681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.
    Berardelli A; Wenning GK; Antonini A; Berg D; Bloem BR; Bonifati V; Brooks D; Burn DJ; Colosimo C; Fanciulli A; Ferreira J; Gasser T; Grandas F; Kanovsky P; Kostic V; Kulisevsky J; Oertel W; Poewe W; Reese JP; Relja M; Ruzicka E; Schrag A; Seppi K; Taba P; Vidailhet M
    Eur J Neurol; 2013 Jan; 20(1):16-34. PubMed ID: 23279440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.